Skip to main content
C

Chunghwa Chemical Synthesis & Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 1762 TW Manufacturing
Filings indexed 1,573 across all filing types
Latest filing 2023-11-07 Regulatory Filings
Country TW Taiwan
Listing TW 1762

About Chunghwa Chemical Synthesis & Biotech Co., Ltd.

https://www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司董事會通過對財團法人王民寧先生紀念基金會捐贈案
Regulatory Filings
2023-11-07 Chinese
公告本公司董事會通過112年第三季合併財務報告
Regulatory Filings
2023-11-07 Chinese
112年10月內部人持股異動(事後)
Regulatory Filings
2023-11-07 Chinese
112年10月董事會成員及持股
Regulatory Filings
2023-11-07 Chinese
112年9月背書保證與資金貸與
Regulatory Filings
2023-10-06 Chinese
112年9月營業收入
Regulatory Filings
2023-10-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.